About Leslie Williams
Leslie Williams is a director at Axelyf.
Experience
This experience comes from Leslie Williams's profile and from SEC filings. For roles taken from filings, the years are when the filings name Leslie Williams in the role, so the role may have started earlier or lasted longer.
DB
DaCapo Brainscience Current
President & CEO
2026 – Present
Axelyf, Inc. Current
Member Board of Directors
2025 – Present · Chestnut Hill, MA
Develops RNA medicines for people with cancer and autoimmune diseases.
MA
MassBio Current
Member Board of Directors
2025 – Present
MI
Make-A-Wish® Massachusetts and Rhode Island Current
Member Board of Directors
2025 – Present
TF
The Termeer Foundation Current
Mentor
2025 – Present
BO
Biotechnology Innovation Organization Current
Member Board of Directors
2024 – Present
OI
Ocular Therapeutix, Inc. Current
Board Member, Nom/Gov Committee, Comp Committee
2019 – Present
HI
HC Bioscience, Inc.
Co-Founder, President & CEO
2020 – 2025
WI
Windtree Therapeutics, Inc.
Member Board Of Directors, Chair Nom & Gov, Member Audit Committee
2021 – 2024
BB
Boston University Questrom School of Business
Guest Lecturer
2017 – 2020
UI
University of Iowa
Executive Board Member - College of Pharmacy
2015 – 2019
II
ImmusanT, Inc.
Founder, President & CEO
2010 – 2019
TN
The Capital Network
Board Director
2009 – 2016
HC
Hepregen Corporation
Board Director
2008 – 2014
CB
CDI Bioscience
Board of Directors
2006 – 2011
BL
Battelle Ventures LP
Venture Partner
2008 – 2009
VP
Ventaira Pharmaceuticals
CEO & President & Board Director
2003 – 2007
II
IKARIA, Inc. - now a part of Mallinckrodt Pharmaceuticals. (INO Therapeutics/Ikaria)
Director of Sales & Marketing
1996 – 2003
DO
Datex-Ohmeda
Project management/Account Manager
1993 – 1996
Key Colleagues at Startups
The people Leslie Williams works with at each company, as listed on that company's latest Form D.
Axelyf, Inc. · Form D, Oct 13, 2026
OA
Orn Almarsson
CEO, Co-founder and director
AB
Arni Blondal
Director